Target intelligence / Profile preview

beneficial gut microbiota

Molecular classification
Other (Microbial community, not a discrete molecular entity)
01

Overview

Beneficial gut microbiota" refers to populations of bacteria, archaea, fungi, and viruses in the gastrointestinal tract that support host health by performing functions such as nutrient metabolism, maintaining the gut barrier, modulating immune responses, excluding pathogens, and producing vital metabolites. This community is not a single entity but a diverse, dynamic ecosystem that varies between individuals and throughout life. Changes or disruption in its composition (dysbiosis) have been implicated in the pathogenesis of a wide range of diseases, including inflammatory, metabolic, neurodegenerative, and neoplastic disorders. Therapeutic strategies are being investigated to restore or support beneficial gut microbiota through approaches such as diet, probiotics, prebiotics, synbiotics, targeted antibiotics, and fecal microbiota transplantation[1][2][6][7][9]. The term does not describe a single, druggable target but rather a class of mixed organisms collectively essential for healthy human physiology.

Other names
gut microbiotagut microfloragut microbiomegut floraintestinal microbiota
02

Mechanism of action

Restoration or modulation of microbial composition (through probiotics, prebiotics, synbiotics, fecal microbiota transplantation); Modulation of microbial metabolism to affect drug activation, immune response, or nutrient production; Inhibition of specific bacterial enzymes to improve drug efficacy/safety (e.g., β-glucuronidase inhibitors)

03

Biological functions

Nutrient metabolism (extraction, synthesis, absorption of nutrients and metabolites)Maintenance of gut mucosal barrierImmunomodulation (regulation of immune responses, education of innate/adaptive immunity)Protection against pathogen colonizationSynthesis of vitamins (e.g., biotin, vitamin K)Production of short-chain fatty acids (SCFAs)Fermentation of unused substratesRegulation of host metabolism and fat storageModulation of central nervous system and behavior via the gut-brain axis
04

Disease associations

Inflammation (intestinal and systemic)Metabolic diseases (obesity, diabetes)Neurodegenerative diseases (e.g., Parkinson's, Alzheimer's)Colorectal cancerAutoimmune and extraintestinal disordersInfection (loss of beneficial microbiota can facilitate infection)Other (wide association with multiple disease states)
05

Safety considerations

Risk of infection with fecal microbiota transplantationAntibiotic resistance developmentPotential transfer of undesirable traits in microbiota-based therapiesUnintended metabolic or immune effects
06

Interacting drugs

Probiotics (live beneficial bacteria)

6 more in the full profile.

07

Biomarkers

Microbial diversity measures (e.g., Shannon index)Relative abundance of beneficial genera/species (e.g., Bifidobacterium, Lactobacillus, Faecalibacterium prausnitzii)Short-chain fatty acid levelsMicrobiota-derived metabolites (e.g., secondary bile acids, neurotransmitters)

Beyond the preview

Go deeper on beneficial gut microbiota.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on beneficial gut microbiota.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call